New Orleans, LA, United States of America

Robert F Garry

USPTO Granted Patents = 34 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 14)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 101(Granted Patents)

Company Filing History:

27 out of 240

The Administrators of the Tulane Educational Fund

patents

10 out of 11

Autoimmune Technologies, LLC

patents

3 out of 712

The Rockefeller University

patents

4. 2 out of 5,444

University of Texas System

patents

5. 1 out of 8,684

US Government As Represented by the Secretary of the Army

patents

6. 1 out of 1

The Administrators of the Tulane

patent

7. 1 out of 1

Educational Fund and Autoimmune Technologies, LLC

patent

8. 1 out of 4

The Administration of the Tulane Educational Fund

patents

9. 1 out of 1

The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC

patent

10. 1 out of 5

Florida Gulf Coast University

patents

11. 1 out of 1,186

The Scripps Research Institute

The Rockfeller University

patents

14. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358971 - Arena virus monoclonal antibodies and uses (2025-07-15),

2. 11198723 - Arenavirus monoclonal antibodies and uses (2021-12-14),

3. 11123427 - Immunoprotective primary mesenchymal stem cells and methods (2021-09-21),

4. 10537634 - Immunogenic peptide composition and method (2020-01-21),

5. 10472647 - Primary mesenchymal stem cells as a vaccine platform (2019-11-12),

6. 10357562 - Immunoprotective primary mesenchymal stem cells and methods (2019-07-23),

7. 10137194 - Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith (2018-11-27),

8. 9725487 - Compositions and methods for measles virus inhibition (2017-08-08),

9. 9649375 - Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith (2017-05-16),

10. 9556237 - Antiviral rift valley fever virus peptides and methods of use (2017-01-31),

11. 9434769 - Peptide compositions and methods for inhibiting herpesvirus infection (2016-09-06),

12. 9353157 - Influenza inhibiting compositions and methods (2016-05-31),

13. 9101597 - Immunoprotective primary mesenchymal stem cells and methods (2015-08-11),

14. 9056900 - Compositions and methods for coronavirus inhibition (2015-06-16),

15. 8999925 - Arenavirus inhibiting peptides and uses therefor (2015-04-07),

Title: The Innovative Journey of Robert F. Garry

Introduction: Robert F. Garry is a renowned inventor based in New Orleans, LA (US) known for his groundbreaking contributions to the field of innovations and inventions.

Latest Patents: Robert F. Garry holds several patents in the areas of biotechnology and medical devices, with his most recent patent focusing on a novel method for early detection of infectious diseases.

Career Highlights: With a career spanning over two decades, Robert F. Garry has established himself as a leading figure in the world of inventors. He has received numerous accolades for his innovative work, including the prestigious Inventor of the Year award.

Collaborations: Throughout his career, Robert F. Garry has collaborated with top research institutions, universities, and biotech companies to further his inventions. His collaborative efforts have led to the development of cutting-edge technologies that have revolutionized the field.

Conclusion: In conclusion, Robert F. Garry's passion for innovation and dedication to his craft have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.